American Oriental Bioengineering Inc (AOBI)

American Oriental Bioengineering Inc. is a common stock listing on OTC Markets. The company develops, manufactures, and commercializes pharmaceutical and healthcare products in China, with activities spanning prescription medicines, over-the-counter treatments, and nutraceuticals. Its prescription portfolio includes Shuanghuanglian Lyophilized Injection Powder, marketed under the SHL brand for flu symptoms and certain respiratory infections, and Cease Enuresis Soft Gel under the CE Gel brand for bedwetting. The company also sells OTC products such as Cease Enuresis Patch, Jinji Capsule, Jinji Yimucao, and Boke Nasal Spray, which are used for conditions including incontinence, pelvic inflammation, PMS-related symptoms, and nasal congestion. In addition, it produces soybean peptide-based nutraceutical drinks, tablets, powders, and instant coffee, and it participates in the wholesale and retail distribution of pharmaceutical and nutraceutical products. American Oriental Bioengineering is headquartered in Beijing, China.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.